Table 2.
Baseline demographics of the study cohort grouped by CKD stage
| CKD stage 1–2 (n = 29) |
CKD stage 3–4 (n = 24) |
|||
|---|---|---|---|---|
| IgAN (n = 16) |
Non-IgAN GNs (n = 13) |
IgAN (n = 19) |
Non-IgAN GNs (n = 5) |
|
| Age (yrs) | 37.50 (25.0–54.5) | 40 (30.0–47.0) | 57.00 (46.0–64.0) | 44.00 (34.0–45.0) |
| Males (%) | 87.50 | 38.46 | 89.47 | 60.00 |
| Blood pressure (mmHg) | ||||
| Systolic | 115 (109–128) | 115 (111–121) | 127 (117–139) | 126 (114–143) |
| Diastolic | 72 (70–76) | 75 (74–77) | 82 (71–86) | 78 (71–97) |
| BMI (kg/m2) | 26.21 (24.23–30.22) | 27.55 (24.34–28.74) | 27.71 (24.98–30.93) | 26.88 (25.99–27.42) |
| Current smoker (%) | 6.25 | 38.46 | 26.32 | 20.00 |
| Immunosuppression (n/total) | 1/16 | 10/13 | 1/19 | 5/5 |
| eGFR (ml/min/1.73 m2) | 83.80 (70.05–96.55) | 97.70 (84.6–105.1) | 36.50 (22.50–49.40) | 45.40 (36.10–50.90) |
| Creatinine (mg/dl) | 1.09 (0.99–1.16) | 0.92 (0.72–0.98) | 1.93 (1.64–2.99) | 1.73 (1.70–1.96) |
| Proteinuria (g/d) | 0.38 (0.15–0.79) | 0.19 (0.14–0.55) | 0.47 (0.19–0.95) | 0.18 (0.10–0.31) |
Values are presented as medians and Interquartile Range (IQR) or percentages. CKD, chronic kidney disease
BMI body mass index, eGFR estimated glomerular filtration rate